Wei Zhang1, Hui Juan Chen1, Zhen J Wang2, Wei Huang3, Long Jiang Zhang4. 1. Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, 210002, China. 2. Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. 3. Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, 210002, China. radiology@126.com. 4. Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, 210002, China. kevinzhlj@163.com.
Abstract
PURPOSE: To investigate whether dynamic contrast -enhanced MRI (DCE-MRI) can distinguish the type of liver nodules in a rat model with N-nitrosodiethylamine- induced cirrhosis. METHODS: Liver nodules in cirrhosis were induced in 60 male Wistar rats via 0.01 % N-nitrosodiethylamine in the drinking water for 35-100 days. The nodules were divided into three groups: regenerative nodule (RN), dysplastic nodule (DN), and hepatocellular carcinoma (HCC). DCE-MRI was performed, and parameters including transfer constant (Ktrans), rate constant (Kep), extravascular extracellular space volume fraction (Ve), and initial area under the contrast concentration versus time curve (iAUC) were measured and compared. RESULTS: The highest Ktrans and iAUC values were seen in HCC, followed by DN and RN (all P < 0.05). The area under the receiver operating characteristic curve (AUROC) for DN and HCC were 0.738 and 0.728 for Ktrans and iAUC, respectively. The AUROC for HCC were 0.850 and 0.840 for Ktrans and iAUC, respectively. Ordinal logistic regression analysis showed that Ktrans had a high goodness of fit (0.970, 95 % confidence interval, 13.751-24.958). CONCLUSION: DCE-MRI is a promising method to differentiate of liver nodules. Elevated Ktrans suggested that the nodules may be transformed into HCC. KEY POINTS: • DCE-MRI is promising for differentiating among RN, DN, and HCC • K trans and iAUC positively correlated with malignancy degree of liver nodules • Elevated K trans suggests that the nodules may be transformed into HCC.
PURPOSE: To investigate whether dynamic contrast -enhanced MRI (DCE-MRI) can distinguish the type of liver nodules in a rat model with N-nitrosodiethylamine- induced cirrhosis. METHODS: Liver nodules in cirrhosis were induced in 60 male Wistar rats via 0.01 % N-nitrosodiethylamine in the drinking water for 35-100 days. The nodules were divided into three groups: regenerative nodule (RN), dysplastic nodule (DN), and hepatocellular carcinoma (HCC). DCE-MRI was performed, and parameters including transfer constant (Ktrans), rate constant (Kep), extravascular extracellular space volume fraction (Ve), and initial area under the contrast concentration versus time curve (iAUC) were measured and compared. RESULTS: The highest Ktrans and iAUC values were seen in HCC, followed by DN and RN (all P < 0.05). The area under the receiver operating characteristic curve (AUROC) for DN and HCC were 0.738 and 0.728 for Ktrans and iAUC, respectively. The AUROC for HCC were 0.850 and 0.840 for Ktrans and iAUC, respectively. Ordinal logistic regression analysis showed that Ktrans had a high goodness of fit (0.970, 95 % confidence interval, 13.751-24.958). CONCLUSION:DCE-MRI is a promising method to differentiate of liver nodules. Elevated Ktrans suggested that the nodules may be transformed into HCC. KEY POINTS: • DCE-MRI is promising for differentiating among RN, DN, and HCC • K trans and iAUC positively correlated with malignancy degree of liver nodules • Elevated K trans suggests that the nodules may be transformed into HCC.
Authors: James P B O'Connor; Alan Jackson; Geoff J M Parker; Caleb Roberts; Gordon C Jayson Journal: Nat Rev Clin Oncol Date: 2012-02-14 Impact factor: 66.675
Authors: Andrew X Zhu; Dushyant V Sahani; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Onofrio A Catalano; Vivek Sindhwani; Lawrence S Blaszkowsky; Sam S Yoon; Johanna Lahdenranta; Pankaj Bhargava; Jeffrey Meyerhardt; Jeffrey W Clark; Eunice L Kwak; Aram F Hezel; Rebecca Miksad; Thomas A Abrams; Peter C Enzinger; Charles S Fuchs; David P Ryan; Rakesh K Jain Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: M O Leach; B Morgan; P S Tofts; D L Buckley; W Huang; M A Horsfield; T L Chenevert; D J Collins; A Jackson; D Lomas; B Whitcher; L Clarke; R Plummer; I Judson; R Jones; R Alonzi; T Brunner; D M Koh; P Murphy; J C Waterton; G Parker; M J Graves; T W J Scheenen; T W Redpath; M Orton; G Karczmar; H Huisman; J Barentsz; A Padhani Journal: Eur Radiol Date: 2012-05-07 Impact factor: 5.315
Authors: P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff Journal: J Magn Reson Imaging Date: 1999-09 Impact factor: 4.813
Authors: Keiko Miyazaki; Neil P Jerome; David J Collins; Matthew R Orton; James A d'Arcy; Toni Wallace; Lucas Moreno; Andrew D J Pearson; Lynley V Marshall; Fernando Carceller; Martin O Leach; Stergios Zacharoulis; Dow-Mu Koh Journal: Eur Radiol Date: 2015-03-15 Impact factor: 5.315
Authors: Klaus Mross; Ulrike Fasol; Annette Frost; Robin Benkelmann; Jan Kuhlmann; Martin Büchert; Clemens Unger; Hubert Blum; Jürgen Hennig; Tsveta P Milenkova; Jean Tessier; Annetta D Krebs; Anderson J Ryan; Richard Fischer Journal: J Angiogenes Res Date: 2009-09-21
Authors: Johannes Budjan; Ulrike I Attenberger; Stefan O Schoenberg; Hubertus Pietsch; Gregor Jost Journal: Eur Radiol Date: 2017-12-07 Impact factor: 5.315
Authors: Ryan M Kiefer; Stephen J Hunt; Santiago Pulido; Stephen Pickup; Emma E Furth; Michael C Soulen; Gregory J Nadolski; Terence P Gade Journal: J Vasc Interv Radiol Date: 2017-05-09 Impact factor: 3.464
Authors: Ahmed W Moawad; Janio Szklaruk; Chandana Lall; Katherine J Blair; Ahmed O Kaseb; Amita Kamath; Scott A Rohren; Khaled M Elsayes Journal: J Hepatocell Carcinoma Date: 2020-04-23